Search Within

Marc Rosenblum

  1. "Department of Medicine"
Formats
  1. Journal Article (37)
  2. Meeting Abstract (13)
Groups
  1. Department of Medicine (50)
  2. Department of Pathology and Laboratory Medicine (50)
  3. GSK Faculty (31)
  4. Solid Tumor Oncology Division (28)
  5. Tow Center for Developmental Oncology (TCDO) (24)
  6. Center for Hematologic Malignancies (23)

More Groups

People
  1. Eli Diamond (11)
  2. Elena Pentsova (9)
  3. Benjamin Durham (8)
  4. Lisa De Angelis (8)
  5. Michael Berger (8)
  6. Omar Abdel-Wahab (8)

More People

Years
  1. 2024 (4)
  2. 2023 (5)
  3. 2022 (1)
  4. 2021 (5)
  5. 2020 (2)
  6. 2019 (2)

More Years

Publications
  1. Journal of Neuro-Oncology (5)
  2. Neuro-Oncology (5)
  3. Blood (3)
  4. Journal of Clinical Oncology (3)
  5. Modern Pathology (3)
  6. Open Forum Infectious Diseases (3)

More Publications

Publishers
  1. Oxford University Press (9)
  2. American Association for Cancer Research (6)
  3. Springer (6)
  4. American Society of Clinical Oncology (4)
  5. Nature Publishing Group (4)
  6. American Society of Hematology (3)

More Publishers

Results (50)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective germline sequencing of patients with gliomas, glioneuronal or neuronal tumors
    Meeting Abstract

    Lin, A.; Nandakumar, S.; Mehine, M.; Kemel, Y.; Mandelker, D.; Karajannis, M.; Sait, S. F.; Gavrilovic, I.; Pentsova, E.; Schaff, L.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Direct patient outreach in pediatric neurooncology to improve access to genomic profiling – The make-an-impact program
    Meeting Abstract

    Sait, S. F.; O'Donohue, T.; Hill, K.; Stockfish, E.; Giantini-Larsen, A.; Alano, T.; Bale, T.; Rosenblum, M.; Benhamida, J.; Dunkel, I.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
    Journal Article

    Friedman, J. S.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Dogan, A.; Pulitzer, M.; Busam, K. J.; Francis, J. H.; Rampal, R. K.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors
    Journal Article

    Lin, A. L.; Rudneva, V. A.; Richards, A. L.; Zhang, Y.; Woo, H. J.; Cohen, M.; Tisnado, J.; Majd, N.; Wardlaw, S. L.; Page-Wilson, G.; more...
    Acta Neuropathologica (2024)

    Fulltext@MSK | Save
  • Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT
    Journal Article

    McLaughlin, L. A.; Yildirim, O.; Rosenblum, M. K.; Imber, B. S.; Haseltine, J. M.; Zelefsky, M. J.; Schöder, H.; Morris, M. J.; Rafelson, W. M.; Krebs, S.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Overcoming barriers to tumor genomic profiling through direct-to-patient outreach
    Journal Article

    Doe-Tetteh, S. A.; Camp, S. Y.; Reales, D.; Crowdis, J.; Noronha, A. M.; Wolff, B.; Alano, T.; Galle, J.; Selcuklu, S. D.; Viale, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Expanding the molecular diversity of CIC-rearranged sarcomas with novel and very rare partners
    Journal Article

    Linos, K.; Dermawan, J. K.; Bale, T.; Rosenblum, M. K.; Singer, S.; Tap, W.; Dickson, M. A.; Hornick, J. L.; Antonescu, C. R.
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • A multinational series of 26 patients with mixed histiocytic neoplasms highlighting a diverse mutational landscape and superior efficacy of targeted therapies
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Ulaner, G. A.; Reddy, R.; Lacouture, M. E.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Yabe, M.; Petrova-Drus, K.; Rosenblum, M.; Rotemberg, V.; Lacouture, M. E.; Rampal, R.; Francis, J.; Knoerzer, D.; Kreider, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save